A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150µg of Nestorone and 15µg of Ethinyl Estradiol (150/15 NES/EE CVR)

Trial Profile

A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150µg of Nestorone and 15µg of Ethinyl Estradiol (150/15 NES/EE CVR)

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Elcometrine (Primary) ; Ethinylestradiol (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2008 The expected completion date for this trial is now 1 Jun 2009 according to ClinicalTrials.gov.
    • 22 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 11 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top